logo
Select company
Select metric
-971.78%EBITDA Margin
VS
Market
5
Sector
19
Industry
-
History
50
$ 0.61Close
$ 0.34 - $ 1.77 52-Week Range
Ticker Information

Ticker

FEMY

Company Name

FEMASYS INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

FEMASYS INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FEMY - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -18.34M-971.78%$ 1.89M
3/31/2025$ -18.54M-1091.19%$ 1.7M
12/31/2024$ -16.33M-1002.48%$ 1.63M
9/30/2024$ -15.89M-1260.08%$ 1.26M
6/30/2024$ -14.84M-1562.41%$ 950.1K
3/31/2024$ -13.45M-1281.79%$ 1.05M
12/31/2023$ -13.17M-1228.52%$ 1.07M
9/30/2023$ -11.83M-1082.45%$ 1.09M
6/30/2023$ -10.85M-907.15%$ 1.2M
3/31/2023$ -10.57M-896.79%$ 1.18M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FEMASYS INC's latest trailing twelve months (TTM) EBITDA % stands at -555.26%.
  • Over the past 5 years, FEMASYS INC's average EBITDA % has been -998.12%.
  • The median EBITDA % for FEMASYS INC during this period was -971.78%
  • FEMASYS INC reached its highest EBITDA % over the past 5 years at -555.26%.
  • The lowest EBITDA % recorded by FEMASYS INC in the same timeframe -1562.41%

FEMASYS INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
LUCY : INNOVATIVE EYEWEAR INC -383.4%CLSD : CLEARSIDE BIOMEDICAL INC -1984.67%IGC : IGC PHARMA INC -432.93%POAI : PREDICTIVE ONCOLOGY INC -847.68%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -1330.98%LSTA : LISATA THERAPEUTICS INC -1842.52%PLUR : PLURI INC -1586.3%LGVN : LONGEVERON INC -838.3%CAMP : CAMP4 THERAPEUTICS CORP -1603.86%RANI : RANI THERAPEUTICS HOLDINGS INC -1841.83%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for FEMASYS INC is calculated as follows: EBITDA [ $ -6.55M ] / Revenues [ $ 1.18M ]
(=) EBITDA % [ -555.26% ]

FEMY - EBITDA Margin, Last 5 years

-1562.41%

Minimum

Jun 30, 2024

-555.26%

Maximum

Dec 31, 2021

-998.12%

Average

-971.78%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%